Send feedback

MECP2 p.Pro185Ala

c.553C>G · rs61748427 · VCV143608

Likely benign Expert panel
Classification
Likely benign
ClinVar
Review
Expert panel ★★★☆
ClinVar · 10 submitters
AlphaMissense
likely benign
0.0811 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00145%, nfe)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
5
Rett syndrome

ClinGen expert panel — Rett and Angelman-like Disorders VCEP

Likely Benign for Rett syndrome. Applied ACMG criteria (verbatim):

BS2 BP5

Curation rationale (ClinGen, verbatim)

The p.Pro173Ala variant in MECP2 (NM_004992.3) has been reported in an individual with a clinical phenotype suggestive of Rett syndrome; this individual was reported to have a second variant in MECP2 that was classified as Pathogenic (PMID 11241840). The p.Pro173Ala variant in MECP2 (NM_004992.3) is observed in at least 2 unaffected individuals (internal database - GeneDx; internal database - Invitae) (BS2). The p.Pro173Ala variant is found in at least 2 patients with an alternate molecular basis of disease (internal database - GeneDx; internal database - Invitae) (BP5). The p.Pro173Ala variant in MECP2 is present in 3 female and 2 male individual(s) in gnomAD (0.0024%) (not sufficient to meet BS1 criteria). In summary, the p.Pro173Ala variant in MECP2 is classified as Likely Benign based on the ACMG/AMP criteria (BS2, BP5).

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.0811likely benign
REVEL0.5indeterminate
SaProtLLR -8.20tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 8.5GERP 0.2, phastCons 1
Regional constrainto/e 1.55unconstrained · MANE · 1,052 bp · p 2.6e-22 · regional, not allelic
Overall
CADD23.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM P173A vs ClinVar P185A) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00145% European (non-Finnish) · 13/895,313 alleles
Filtering AF 0.00081% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000624%
Overall 0.00107% 13/1,210,462 alleles · very rare

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MECP2
Protein
p.Pro185Ala
Coding
c.553C>G
MANE Select
NM_001110792
dbSNP
rs61748427
Type
single nucleotide variant
Location
chrX:154031311 (GRCh38)
Structure
AlphaFold pLDDT 57.25 · 11 PDB
Residue 185
a DNA-binding region; the 'disordered' region
Full MECP2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mecp2-p-pro185ala (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown